North America Breast Reconstruction Market

Market Introduction

Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.

Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.

The COVID-19 pandemic has impacted breast surgeries also in a pervasive manner. The sudden situation has stimulated breast and plastic surgeons, healthcare decision-makers, and policymakers, who have met with the need to expeditiously implement containment measures to mitigate the impact of the COVID-19 pandemic. Moreover, on March 13th, 2020, the American College of Surgeons (ACS) suggested that hospitals, health institutions, and surgeons across the nation reduce, postpone or cancel electively scheduled operations, including breast reconstruction procedures. The surgeries were canceled to maximize bed space, maintain personal protective equipment, and reduce the risk of transmission amongst patients and providers. Furthermore, the COVID-19 pandemic has undeniably introduced even more panic and fear into the previously anxiety-provoking situation of a breast cancer diagnosis.  As per the report published by Anticancer Research in 2021, nearly half (44.2%) of the patients showed that breast reconstruction was not occurring at their institutions during the pandemic, whether that was by a delay of all oncologic treatment hormone/chemotherapy alone or mastectomy alone. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from breast reconstruction to coronavirus diagnosis and treatment devices are leading to a decline in breast reconstruction, leading to a decrease in market growth up to the certain extent.

Market Overview and Dynamics

The Breast reconstruction market in North America is expected to grow from US$ 312.2 million in 2021 to US$ 482.1 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Patients undergoing unilateral or bilateral mastectomy procedures usually opt for breast reconstruction for regaining the original shape of the breasts and improving their aesthetic appeal, among other factors. Thus, it is important for the market players to come up with innovative products that would marginally boost the adoption of this procedure. Tissue expander is one such innovation that eases the task of surgeons and improves the effectiveness of the reconstruction procedures. In December 2016, the US Food and Drug Administration (FDA) approved the marketing of the AeroForm tissue expander offered by AirXpanders; it is a needle-free alternative for patients undergoing breast reconstruction procedure. Moreover, in April 2018, Sientra, Inc. showcased its modern breast implants at the American Society of Aesthetic Plastic Surgeons Meeting 2018. In September 2020, POLYTECH Health & Aesthetics GmbH announced the launch of its expanded B-Lite portfolio, which is consists of the world's first and only lightweight breast implants. Thus, the capitalization in innovative technologies to come up with breakthrough products is emerging a s key opportunity for the breast construction market players to secure high revenues and marginal profits in the coming years.

Key Market Segments

In terms of technology, the inframammary segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), Sientra Inc., GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, HANSBIOMED CO. LTD, IDEAL IMPLANT INCORPORATED, Establishment Labs S.A., and Groupe Sebbin SAS.

Reasons to buy report

• To understand the North America breast reconstruction market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America breast reconstruction market
• Efficiently plan M&A and partnership deals in North America Breast reconstruction market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Breast reconstruction market
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

NORTH AMERICA BREAST RECONSTRUCTION MARKET SEGMENTATION

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implant’s accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Country

• North America
  • US
  • Canada
  • Mexico

Companies Mentioned

1. Allergan Plc
2. Mentor Worldwide LLC (Subsidiary of Johnson & Johnson)
3. Sientra Inc.
4. GC Aesthetics PLC
5. POLYTECH Health & Aesthetics GmbH
6. HANSBIOMED CO. LTD
7. IDEAL IMPLANT INCORPORATED
8. Establishment Labs S.A.
9. Groupe Sebbin SAS

North America Breast Reconstruction Market Strategic Insights

North America Breast Reconstruction Market Segmentation Analysis

North America Breast Reconstruction Market Report Highlights

North America Breast Reconstruction Report Scope

North America Breast Reconstruction Market Country and Regional Insights